Lavender Sky Health publishes a detailed medication price list and a separate service-pricing page. For sermorelin, the list identifies several pharmacies and formulations. This gives readers more detail than a single starting price, but it also requires keeping medication quantity, route, and clinical charges separate.

We reviewed the public pages on September 20, 2026, without enrolling, ordering medicine, or testing any pharmacy product. CoreAge Rx receives commercial placement on this site. This review examines the purchasing structure and clinical questions rather than ranking pharmacy quality or claiming equivalent results across formulations.

The considered take

Lavender Sky separates consultation fees from medication prices and names several pharmacy options. Compare the complete plan and exact formulation, not a catalog price alone.

The service fee and prescription are separate purchases

The service page lists a $65 new-patient consultation and a $40 follow-up consultation, with medication billed separately. It describes a pay-per-consult model without a monthly membership. The consultation pays for evaluation and does not guarantee that medication will be appropriate.

Ask which consultation applies to you, when follow-up is required, and whether additional assessment or laboratory work has a charge. Do not turn the medication price into an all-in program cost. A patient comparing Lavender Sky with a bundled online offer should record clinical and pharmacy costs separately before totaling the same period of care.

The injection list specifies quantities and pharmacies

The treatment list includes a 15 mg Red Rock option at $199, a 15 mg Hallandale option at $280, and a 30 mg Red Rock option at $249, among other entries. These are listed medication quantities and prices. They are not universal monthly rates or a recommendation to choose a larger vial.

The prescription and beyond-use instructions determine how the supplied medication can be used. Ask the clinician which preparation is appropriate and the pharmacy how the label relates to the prescribed amount. A price-per-milligram calculation cannot establish equivalent care or turn unused medication into useful value. Our cost guide explains the comparison problem.

Oral listings describe different preparations

Lavender Sky lists an Empower ODT, a Hallandale sermorelin/NAD+/B12 capsule, and sermorelin/glycine rapid-dissolve tablets from other pharmacies. The names describe different combinations and dosage forms; they should not be treated as interchangeable ways to take an identical product.

Ask what the clinician is proposing and what evidence supports that route and blend. A larger ingredient list is not proof of more benefit, and a convenient oral form does not establish the same exposure as an injection. The tablets versus injections guide and blends article address those distinct decisions.

A named pharmacy improves the questions you can ask

The named options make it possible to ask about an actual dispensing entity rather than a generic claim about US pharmacies. Confirm which option is available for the product and state involved, and verify the relevant pharmacy details. A name on a menu is not proof that it will be the pharmacy used for your order.

Nor does inclusion on this list establish that one pharmacy's preparation is clinically superior. We have not tested or inspected these products. Use the pharmacy-verification guide for the basic checks and request product-specific instructions after the clinician has selected a prescription.

Read the patient summary beside the actual label

Lavender Sky provides prescription-summary resources organized by product and pharmacy. That can help a patient find relevant instructions, but an educational summary should not override the directions on the dispensed prescription. Confirm any inconsistency before use.

At refill, check the pharmacy, ingredients, concentration, quantity, and dates again. If a different option is used, the old syringe amount or preparation method may no longer apply. Ask for an explanation using the actual supplies. The dosage-language guide and vial-label article explain the information that must stay connected.

Discuss the symptom before choosing from the menu

A detailed list can make selection feel like a shopping exercise, but treatment still requires an appropriate assessment. Ask what condition is being addressed and which benefit would justify continuing. Neither pharmacy choice nor a favorable price establishes that sermorelin will improve a particular symptom.

If the concern relates to menopause, sleep, or low energy, bring that specific history to the visit. The menopause guide explains why a broad hormone-balance claim is not enough, and the fatigue guide covers other explanations that may need assessment. A useful consultation can result in a different plan or no prescription.

Clarify follow-up, refills, and payment records

The service page describes follow-up arrangements, but the individual plan may require earlier review. Ask how a new symptom is handled between scheduled consultations and how a refill request reaches the clinician. Being able to order another supply is not the same as having a treatment review.

Keep the consultation invoice and medication invoice distinct. If you intend to use an HSA or FSA, confirm eligibility for each expense with the applicable administrator rather than assuming all charges qualify because a card is accepted. Our insurance and account guide explains why payment processing and expense eligibility are separate matters.

Our assessment of the model

Lavender Sky's clearest practical distinction is its separation of service fees and pharmacy-specific medication entries. That information can support a careful comparison, especially for a reader who wants to know the proposed dispensing source. It also means the reader needs a complete quote and a clinician-selected preparation before comparing monthly costs.

For a contrasting service presentation, read the CoreAge Rx review or LifeMD review. Compare the actual assessment, formulation, total, and follow-up. This review does not establish response times, state-by-state availability, laboratory quality, or a clinical advantage for any pharmacy named in the catalog.

Sources behind this article

Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.

  1. Lavender Sky Health: Service pricingProvider service page · Medical service charges must be distinguished from medication charges.
  2. Lavender Sky Health: Treatment plan pricingProvider price list · Lists quantities and pharmacy-specific prices; not universal monthly rates or a complete care quote.
  3. FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
  4. Lavender Sky Health: Prescription summariesProvider patient resources · Identifies pharmacy and formulation options; exact prescription and current access need confirmation.
  5. Sigalos and Pastuszak: Safety and efficacy of growth hormone secretagoguesClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
  6. NABP: Buy medication safelyPharmacy regulator association · Tools for checking online pharmacies and recognizing unsafe sellers.
  7. FDA: Risks of compounded drugsUS regulator · Explains lack of FDA approval and the risks of poor-quality compounded preparations.
  8. Mayo Clinic: Sermorelin injection informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
  9. Lavender Sky Health: SermorelinProvider product overview · Several routes and formulations; not evidence of equivalence across them.
  10. Endocrine Society: Adult growth hormone deficiencyClinical practice guideline · Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.
  11. MedlinePlus: FatigueUS National Library of Medicine · Fatigue has many causes that may need evaluation.
  12. IRS: Publication 502, Medical and Dental ExpensesUS tax authority · Medical-expense definitions; not an individual insurance or account-eligibility determination.
  13. IRS: Publication 969, Health Savings Accounts and Other Tax-Favored Health PlansUS tax authority · HSA/FSA qualified-expense and recordkeeping rules. Current accessible edition is for 2025; no 2026 numerical limits are inferred.
  14. CoreAge Rx: Sermorelin product pageProvider primary source · Live product page; starting price is not a verified checkout total.
  15. LifeMD: Men’s health programProvider program page · Contains a sermorelin compounded-product disclosure. Product card and safety text differ on route; no complete sermorelin quote verified.